Reagents
Sustainable recombinant endotoxin detection assay
Jul 03 2024
Introducing PYROSTAR™ Neo+ from Alpha Laboratories
In line with its sustainability ethics, Alpha Laboratories is delighted to introduce the new PYROSTAR™ Neo+ from FUJIFILM Wako. This endotoxin detection reagent has been developed by recombinant technology to provide a synthetic LAL assay alternative, designed with wildlife conservation in mind. This innovative product offers a non-animal derived solution for bacterial endotoxin testing (BET) in research, pharmaceutical, and medical equipment manufacturing. By replacing conventional LAL reagents sourced from Atlantic Horseshoe Crabs, PYROSTAR™ Neo+ helps reduce the impact on wildlife, while facilitating the same high sensitivity as PYROSTAR™ ES-F.
PYROSTAR™ Neo+ utilises a recombinant 3 Factor system that replicates the equivalent cascade reaction of traditional LAL assays. It boasts improved specificity with the absence of Factor G, and eliminates interference due to reaction with β-glucan. Additionally, it has an optimised formulation to support handling of difficult sample matrices which cause interference.
The Neo+ reagent contains a pNA chromogenic group, enabling detection of the assay results on an absorbance plate reader using a colorimetric method recombinant cascade reagent (rCR) assay. The endotoxin test offers clear ethical and environmental advantages over the traditional LAL test, including its compliance with the 3Rs principles of replacement, reduction, and refinement of animal testing.
For a limited time only, save 10% off Neo+. Visit the website or quote offer code PN0724. Offer ends 31st October 2024.
More information online
Digital Edition
Lab Asia 32.1 Feb 2025
February 2025
Chromatography Articles - Comparing volumetric and thermal flowmeters for assessing and validating liquid chromatography performance Mass Spectrometry & Spectroscopy Articles - The importa...
View all digital editions
Events
SPS Smart Production Solutions Guangzhou
Feb 25 2025 Guanghzou, China
Feb 25 2025 Amsterdam, Netherlands
Feb 27 2025 Kathmandu, Nepal
Mar 01 2025 Boston, MA, USA
Mar 02 2025 Bethesda, MD, USA